Cure My Disease

Don't miss your cure!

 Log in / Sign up

Smartphone app aims to boost treatment adherence in teens with scoliosis

NCT ID NCT07686848

Disease control Sponsor: Oslo Metropolitan University Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting This study
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jul 07, 2026 · Last updated Jul 08, 2026 · Updated 1 time

Summary

This study tests a smartphone app called DinSkoliose, designed to help adolescents with idiopathic scoliosis stick to their treatment plan. The app includes features like reminders for brace wear and exercises, symptom tracking, and educational content. Thirty teens will use the app for 12 weeks alongside their usual care, and researchers will measure changes in self-management, motivation, and treatment adherence through questionnaires and interviews.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
DinSkoliose smartphone application
What this could lead to
If effective, the app could offer a simple, low-cost way to help teens with scoliosis stick to their treatment and feel more in control of their condition.
What could go wrong
This is a small, early-stage study with only 30 participants, so results may not apply widely. The app is meant to support, not replace, standard care, and its benefits are uncertain.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 30 people

The number the study aims to enrol. It can still change while the study runs.

Expected to start

Apr 2028

An estimate. Start dates often move.

Expected to finish

Sep 2031

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

10 to 24 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

The study population will consist of adolescent patients with AIS. The Inclusion criteria for participants in our study are those: 1. who are diagnosed with AIS; 2. who give written informed consent, 3. who are at the age between 10 - 24 years old; 4. under 16 years old for whom parental consent has been provided (as required by the National Research Ethics Committee); 5. who can speak, read, and write in Norwegian or English; 6. who have access to and ability to use smart phone; 7. who have internet access. The Exclusion criteria for participants in our study are those who: 1. have a history of other type of scoliosis (such as congenital, neuromuscular, degenerative); 2. are younger than 10 years old and older than 24 years old; 3. have any additional diagnosis that could affect the intervention outcome (severe mental health disorders or diagnosis of a developmental disorder that prevents understanding and compliance with intervention, leg length discrepancy).

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Adolescence idiopathic scoliosis are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

adenocarcinoma in situ adolescent idiopathic scoliosis Alzheimer disease scoliosis Treatment Adherence and Compliance

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Adolescence idiopathic scoliosis AIS

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • OsloMet

    Oslo, 0130, Norway

More trials for these conditions

Other studies related to the condition(s) this trial covers.